In alliance with Concord Biotech, the company has received approval
from the United States Food and Drug Administration (USFDA) to market
Tacrolimus capsules USP, in the strengths of 0.5 mg, 1 mg, and 5 mg,
Lupin said in a filing to the BSE.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-usfda-nod-for-generic-immunosuppressant-capsules/articleshow/79191354.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment